ID   CDKL2_HUMAN             Reviewed;         493 AA.
AC   Q92772; B2R695;
DT   22-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1997, sequence version 1.
DT   10-MAY-2017, entry version 142.
DE   RecName: Full=Cyclin-dependent kinase-like 2;
DE            EC=2.7.11.22;
DE   AltName: Full=Protein kinase p56 KKIAMRE;
DE   AltName: Full=Serine/threonine-protein kinase KKIAMRE;
GN   Name=CDKL2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND SUBCELLULAR
RP   LOCATION.
RC   TISSUE=Fetal brain;
RX   PubMed=9000130;
RA   Taglienti C.A., Wysk M., Davis R.J.;
RT   "Molecular cloning of the epidermal growth factor-stimulated protein
RT   kinase p56 KKIAMRE.";
RL   Oncogene 13:2563-2574(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   VARIANTS [LARGE SCALE ANALYSIS] ILE-98; GLN-149; THR-197 AND VAL-411.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:9000130}.
CC       Nucleus {ECO:0000269|PubMed:9000130}.
CC   -!- TISSUE SPECIFICITY: Expressed in testis and kidney, and at lower
CC       level in brain and lung. {ECO:0000269|PubMed:9000130}.
CC   -!- DOMAIN: The [NKR]KIAxRE motif seems to be a cyclin-binding region.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. CDC2/CDKX subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U35146; AAC50918.1; -; mRNA.
DR   EMBL; AK312490; BAG35392.1; -; mRNA.
DR   EMBL; CH471057; EAX05740.1; -; Genomic_DNA.
DR   EMBL; BC093646; AAH93646.1; -; mRNA.
DR   EMBL; BC093981; AAH93981.1; -; mRNA.
DR   CCDS; CCDS3570.1; -.
DR   RefSeq; NP_001317653.1; NM_001330724.1.
DR   RefSeq; NP_003939.1; NM_003948.4.
DR   RefSeq; XP_016864299.1; XM_017008810.1.
DR   UniGene; Hs.591698; -.
DR   PDB; 4AAA; X-ray; 1.53 A; A=1-308.
DR   PDB; 4BBM; X-ray; 2.00 A; A/B=1-308.
DR   PDBsum; 4AAA; -.
DR   PDBsum; 4BBM; -.
DR   ProteinModelPortal; Q92772; -.
DR   SMR; Q92772; -.
DR   BioGrid; 114479; 7.
DR   IntAct; Q92772; 2.
DR   STRING; 9606.ENSP00000412365; -.
DR   BindingDB; Q92772; -.
DR   ChEMBL; CHEMBL5728; -.
DR   GuidetoPHARMACOLOGY; 1983; -.
DR   iPTMnet; Q92772; -.
DR   PhosphoSitePlus; Q92772; -.
DR   BioMuta; CDKL2; -.
DR   DMDM; 74762639; -.
DR   EPD; Q92772; -.
DR   MaxQB; Q92772; -.
DR   PaxDb; Q92772; -.
DR   PeptideAtlas; Q92772; -.
DR   PRIDE; Q92772; -.
DR   DNASU; 8999; -.
DR   Ensembl; ENST00000429927; ENSP00000412365; ENSG00000138769.
DR   GeneID; 8999; -.
DR   KEGG; hsa:8999; -.
DR   UCSC; uc003hiq.4; human.
DR   CTD; 8999; -.
DR   DisGeNET; 8999; -.
DR   GeneCards; CDKL2; -.
DR   HGNC; HGNC:1782; CDKL2.
DR   HPA; HPA040672; -.
DR   MIM; 603442; gene.
DR   neXtProt; NX_Q92772; -.
DR   OpenTargets; ENSG00000138769; -.
DR   PharmGKB; PA26318; -.
DR   eggNOG; KOG0593; Eukaryota.
DR   eggNOG; ENOG410XNSW; LUCA.
DR   GeneTree; ENSGT00830000128262; -.
DR   HOVERGEN; HBG080204; -.
DR   InParanoid; Q92772; -.
DR   KO; K08824; -.
DR   PhylomeDB; Q92772; -.
DR   TreeFam; TF101031; -.
DR   SignaLink; Q92772; -.
DR   ChiTaRS; CDKL2; human.
DR   GeneWiki; CDKL2; -.
DR   GenomeRNAi; 8999; -.
DR   PRO; PR:Q92772; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000138769; -.
DR   CleanEx; HS_CDKL2; -.
DR   ExpressionAtlas; Q92772; baseline and differential.
DR   Genevisible; Q92772; HS.
DR   GO; GO:0005813; C:centrosome; IDA:HPA.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0004672; F:protein kinase activity; TAS:ProtInc.
DR   GO; GO:1903955; P:positive regulation of protein targeting to mitochondrion; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0007548; P:sex differentiation; TAS:ProtInc.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome; Cytoplasm; Kinase;
KW   Nucleotide-binding; Nucleus; Polymorphism; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    493       Cyclin-dependent kinase-like 2.
FT                                /FTId=PRO_0000085814.
FT   DOMAIN        4    287       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      10     18       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOTIF        45     51       [NKR]KIAxRE.
FT   ACT_SITE    126    126       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      33     33       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   VARIANT      77     77       Y -> S (in dbSNP:rs35921414).
FT                                /FTId=VAR_053928.
FT   VARIANT      98     98       L -> I (in an ovarian papillary serous
FT                                adenocarcinoma sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041987.
FT   VARIANT     132    132       I -> T (in dbSNP:rs17000707).
FT                                /FTId=VAR_053929.
FT   VARIANT     149    149       R -> Q (in an ovarian mucinous carcinoma
FT                                sample; somatic mutation;
FT                                dbSNP:rs755711267).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041988.
FT   VARIANT     197    197       M -> T (in dbSNP:rs56343717).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041989.
FT   VARIANT     411    411       A -> V (in dbSNP:rs56231363).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041990.
FT   HELIX         1      3       {ECO:0000244|PDB:4AAA}.
FT   STRAND        4      9       {ECO:0000244|PDB:4AAA}.
FT   HELIX        10     13       {ECO:0000244|PDB:4AAA}.
FT   STRAND       16     23       {ECO:0000244|PDB:4AAA}.
FT   TURN         24     26       {ECO:0000244|PDB:4AAA}.
FT   STRAND       29     37       {ECO:0000244|PDB:4AAA}.
FT   HELIX        42     57       {ECO:0000244|PDB:4AAA}.
FT   STRAND       66     72       {ECO:0000244|PDB:4AAA}.
FT   STRAND       75     81       {ECO:0000244|PDB:4AAA}.
FT   STRAND       84     86       {ECO:0000244|PDB:4AAA}.
FT   HELIX        87     93       {ECO:0000244|PDB:4AAA}.
FT   HELIX       100    119       {ECO:0000244|PDB:4AAA}.
FT   HELIX       129    131       {ECO:0000244|PDB:4AAA}.
FT   STRAND      132    134       {ECO:0000244|PDB:4AAA}.
FT   STRAND      140    142       {ECO:0000244|PDB:4AAA}.
FT   HELIX       147    150       {ECO:0000244|PDB:4BBM}.
FT   HELIX       154    163       {ECO:0000244|PDB:4BBM}.
FT   HELIX       165    167       {ECO:0000244|PDB:4BBM}.
FT   HELIX       170    173       {ECO:0000244|PDB:4AAA}.
FT   HELIX       182    197       {ECO:0000244|PDB:4AAA}.
FT   HELIX       207    218       {ECO:0000244|PDB:4AAA}.
FT   HELIX       223    231       {ECO:0000244|PDB:4AAA}.
FT   HELIX       233    235       {ECO:0000244|PDB:4AAA}.
FT   HELIX       249    252       {ECO:0000244|PDB:4AAA}.
FT   HELIX       258    267       {ECO:0000244|PDB:4AAA}.
FT   HELIX       272    274       {ECO:0000244|PDB:4AAA}.
FT   HELIX       278    283       {ECO:0000244|PDB:4AAA}.
FT   HELIX       285    288       {ECO:0000244|PDB:4AAA}.
FT   HELIX       289    291       {ECO:0000244|PDB:4AAA}.
FT   HELIX       292    301       {ECO:0000244|PDB:4AAA}.
SQ   SEQUENCE   493 AA;  56019 MW;  5CC20A91CBF89EFE CRC64;
     MEKYENLGLV GEGSYGMVMK CRNKDTGRIV AIKKFLESDD DKMVKKIAMR EIKLLKQLRH
     ENLVNLLEVC KKKKRWYLVF EFVDHTILDD LELFPNGLDY QVVQKYLFQI INGIGFCHSH
     NIIHRDIKPE NILVSQSGVV KLCDFGFART LAAPGEVYTD YVATRWYRAP ELLVGDVKYG
     KAVDVWAIGC LVTEMFMGEP LFPGDSDIDQ LYHIMMCLGN LIPRHQELFN KNPVFAGVRL
     PEIKEREPLE RRYPKLSEVV IDLAKKCLHI DPDKRPFCAE LLHHDFFQMD GFAERFSQEL
     QLKVQKDARN VSLSKKSQNR KKEKEKDDSL VEERKTLVVQ DTNADPKIKD YKLFKIKGSK
     IDGEKAEKGN RASNASCLHD SRTSHNKIVP STSLKDCSNV SVDHTRNPSV AIPPLTHNLS
     AVAPSINSGM GTETIPIQGY RVDEKTKKCS IPFVKPNRHS PSGIYNINVT TLVSGPPLSD
     DSGADLPQME HQH
//
